Author

Chujian Huang

Observed names: Chu-jian Huang, Huang, Chujian

Institution: Chinese Academy of Medical Sciences & Peking Union Medical College

Observed institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Shantou University, Cancer Hospital of Shantou University Medical College

OpenAlex ID: A5085170290

Development and clinical validation of a microfluidic-based platform for CTC enrichment and downstream molecular analysis

2023 · Songhua Cai, Youjun Deng, et al. · Frontiers in Oncology · 24

CTRP6 protects against ferroptosis to drive lung cancer progression and metastasis by destabilizing SOCS2 and augmenting the xCT/GPX4 pathway

2023 · Songhua Cai, Baohui Zhang, et al. · Cancer Letters · 23

Anatomical variation analysis of left upper pulmonary blood vessels and bronchi based on three-dimensional reconstruction of chest CT

2022 · Youjun Deng, Songhua Cai, et al. · Frontiers in Oncology · 12

Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinoma

2021 · Songhua Cai, Xiaotong Guo, et al. · Journal of Translational Medicine · 12

Targeted tumor cell-intrinsic CTRP6 biomimetic codelivery synergistically amplifies ferroptosis and immune activation to boost anti-PD-L1 immunotherapy efficacy in lung cancer

2025 · Songhua Cai, Jing Huang, et al. · Journal of Nanobiotechnology · 10

Efficacy and safety of perioperative sintilimab plus platinum-based chemotherapy for potentially resectable stage IIIB non-small cell lung cancer (periSCOPE): an open-label, single-arm, phase II trial

2024 · Xiangyang Yu, Chujian Huang, et al. · EClinicalMedicine · 10

Comprehensive analysis reveals the prognostic and immunogenic characteristics of DNA methylation regulators in lung adenocarcinoma

2024 · Jing Huang, Chujian Huang, et al. · Respiratory Research · 4

Pembrolizumab treatment in SMARCA4-deficient nonsmall cell lung cancer: high tumor mutational burden and programmed death-ligand 1(+) expression on circulating tumor cells for real-time monitoring: a case report

2025 · Youjun Deng, Yan Huang, et al. · Anti-Cancer Drugs · 3

Survival After Lobectomy vs. Sublobar Resection for Stage IA Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study

2022 · Xiangyang Yu, Mengqi Zhang, et al. · Frontiers in Surgery · 3

[Surgical treatment of Siewert II adenocarcinoma of the esophagogastric junction].

2012 · Yun-sheng Qin, Ye-zhong Zhuang, et al. · PubMed · 2

Exploration of biomarkers in potentially resectable stage IIIB NSCLC patients receiving neoadjuvant chemoimmunotherapy.

2023 · Kai Ma, Chujian Huang, et al. · Journal of Clinical Oncology · 1

Exploring a mutation-based signature to predict the benefits of immune checkpoint inhibitors in oncogene-addicted subsets of non-small cell lung cancer: a retrospective study

2025 · Jing Huang, Jinsong Lei, et al. · Respiratory Research

Efficacy and Safety of Perioperative Sintilimab Plus Platinum-Based Chemotherapy for Potentially Resectable Stage IIIB Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase II Trial

2024 · Xiangyang Yu, Xiangyang Yu, et al. · SSRN Electronic Journal

Additional file 3 of Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinoma

2021 · Cai, Songhua, Guo, Xiaotong, et al. · Figshare

Additional file 2 of Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinoma

2021 · Cai, Songhua, Guo, Xiaotong, et al. · Figshare

Surgical treatment of breast cancer with synchronous metastasis

2011 · Yunsheng Qin, Chujian Huang, et al. · Chin J Endocr Surg

Works count: 16

Citation count: 104

H-index: 6

I10-index: 6